EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Memphasys's enterprise value is €10.91 Mil.
Memphasys's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.03 Mil. Therefore, Memphasys's EV-to-Revenue for today is 376.28.
The historical rank and industry rank for Memphasys's EV-to-Revenue or its related term are showing as below:
STU:IG7'
s EV-to-Revenue Range Over the Past 10 Years
Min: 3.04 Med: 85.96 Max: 158.2
Current: 377.92
During the past 13 years, the highest EV-to-Revenue of Memphasys was 158.20. The lowest was 3.04. And the median was 85.96.
STU:IG7's EV-to-Revenue is ranked worse than 90.93% of 1036
companies
in the Biotechnology industry
Industry Median: 8.285
vs STU:IG7: 377.92
As of today (2024-05-10), Memphasys's stock price is €0.0045.
Memphasys's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00. Therefore, Memphasys's PS Ratio for today is .
Memphasys EV-to-Revenue Historical Data
The historical data trend for Memphasys's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Memphasys's EV-to-Revenue
For the Biotechnology subindustry, Memphasys's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Memphasys's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Memphasys's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Memphasys's EV-to-Revenue falls into.
Memphasys's current Enterprise Value is €10.91 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Memphasys's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Memphasys's share price for today is €0.0045.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Memphasys EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Memphasys's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:IG7 has been successfully added to your 